Evidence map›Paper›PMID 38017588›Full record

ReviewCell & bioscience2023

Therapeutic uses of oxytocin in stress-related neuropsychiatric disorders.

Sen Zhang, Ying-Dan Zhang, Dong-Dong Shi, Zhen Wang

Open access · goldAbstract readReview
In one paragraph

Review in Cell & bioscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. First-in-human intranasal [EJNMMI research · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Facing stress and inflammation: From the cell to the planet.World journal of experimental medicine · 2024
    Review
  12. Article
  13. Review
  14. Birth Rate as a Determinant of Dementia Incidence: A Comprehensive Global Analysis.American journal of Alzheimer's disease and other dementias
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sen ZhangShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 600 Wan Ping Nan Road, Shanghai, 200030, China.
Ying-Dan ZhangShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 600 Wan Ping Nan Road, Shanghai, 200030, China.
Dong-Dong ShiShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 600 Wan Ping Nan Road, Shanghai, 200030, China. laural.dong.shi@gmail.com.
Zhen WangShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 600 Wan Ping Nan Road, Shanghai, 200030, China. wangzhen@smhc.org.cn.
Shanghai Jiao Tong University · CNShanghai Mental Health Center · CN

Funding

Lingang Laboratory LG202106-03-02National Natural Science Foundation of China 31900730National Natural Science Foundation of China 32271066National Natural Science Foundation of China 82230045Shanghai Municipal Education Commission 20161321Shanghai Municipal Education Commission 2021-01-07-00-02-E0086Shanghai Science and Technology Committee 20XD1423100
6 · The paper itself

Abstract

Oxytocin (OXT), produced and secreted in the paraventricular nucleus and supraoptic nucleus of magnocellular and parvocellular neurons. The diverse presence and activity of oxytocin suggests a potential for this neuropeptide in the pathogenesis and treatment of stress-related neuropsychiatric disorders (anxiety, depression and post-traumatic stress disorder (PTSD)). For a more comprehensive understanding of the mechanism of OXT's anti-stress action, the signaling cascade of OXT binding to targeting stress were summarized. Then the advance of OXT treatment in depression, anxiety, PTSD and the major projection region of OXT neuron were discussed. Further, the efficacy of endogenous and exogenous OXT in stress responses were highlighted in this review. To augment the level of OXT in stress-related neuropsychiatric disorders, current biological strategies were summarized to shed a light on the treatment of stress-induced psychiatric disorders. We also conclude some of the major puzzles in the therapeutic uses of OXT in stress-related neuropsychiatric disorders. Although some questions remain to be resolved, OXT has an enormous potential therapeutic use as a hormone that regulates stress responses.

Indexed as

AnxietyDepressionNeural circuitsOxytocinStress-related neuropsychiatric disorders

Identifiers

PMID38017588
PMCPMC10683256
OpenAlexW4389077866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.